Kevin C.J. Yuen

Creighton University — United States

Medicine · Health Sciences

43h-index9.0kcitations244works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Growth Hormone and Insulin-like Growth Factors(135), Pituitary Gland Disorders and Treatments(108), Adrenal and Paraganglionic Tumors(28), Adrenal Hormones and Disorders(27), Diet and metabolism studies(25)

Publications239 total

Corrigendum to “Medical treatment of hypercortisolism with relacorilant: Final results of the phase 3 GRACE study” [American Heart Journal 278S (2024) Pages 10-11]
American Heart Journal·2025Open Access
Cabergoline-Induced Gambling Causing Increased Adrenal Crisis Episodes
JCEM Case Reports·2025· 1 citedOpen Access
Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort study
The Lancet Diabetes & Endocrinology·2025· 1 citedOpen Access
Development and validation of clinical screening systems for Cushing disease in the United States
Pituitary·2025Open Access
SAT-046 The Influence of BMI, Weight and Body Composition on Peak Growth Hormone Response to Glucagon Stimulation in a Traumatic Brain Injury Population
Journal of the Endocrine Society·2025Open Access
MON-028 Symptom Improvement in an Ulcerative Colitis Patient Following 6-Month Recombinant Human Growth Hormone Therapy: A Case Report
Journal of the Endocrine Society·2025Open Access
MON-068 Cabergoline Induced Pathological Gambling Causing Increased Episodes of Adrenal Crisis in a Patient with Acromegaly and Secondary Adrenal Insufficiency
Journal of the Endocrine Society·2025Open Access
Préférences des patients et des soignants pour les dispositifs d’injection hebdomadaire dans le traitement du GHD chez l’adulte
Annales d Endocrinologie·2025
Osilodrostat Treatment for Cushing Syndrome: 5 Years on Since Regulatory Approval
Endocrine Practice·2025
Long-acting Growth Hormone Preparations
Endocrinology and Metabolism Clinics of North America·2025
Development of a Minimum Dataset for the Global Monitoring of the Safety and Efficacy of Growth Hormone Replacement in Adults With Growth Hormone Deficiency (AGHD)
Clinical Endocrinology·2025Open Access
Three Cases of Ectopic, Cyclic Cushing Syndrome: A New Square Wave Variant
JCEM Case Reports·2025Open Access
Growth Hormone and Bone: Preclinical and Clinical Perspectives
Endocrine Practice·2025· 3 cited
Management of Osilodrostat Therapy in Patients With Cushing's Syndrome: A Modified Delphi Consensus Panel
Journal of the Endocrine Society·2025· 3 citedOpen Access
Medical treatment of hypercortisolism with relacorilant: Final results of the phase 3 GRACE study
Endocrine Abstracts·2025· 1 cited
Efficacy and safety of once-weekly somatrogon in adults with growth hormone deficiency: a phase 3 study
Endocrine Abstracts·2025
Clofutriben inhibits 11sz-hydroxysteroid dehydrogenase type 1 and improves ACTH-dependent cushing's syndrome compared with placebo in a phase II trial (RESCUE)
Endocrine Abstracts·2025
Results of the foresiGHt trial support the efficacy and safety of once-weekly lonapegsomatropin in adults with growth hormone deficiency (GHD)
Endocrine Abstracts·2025
Consensus and controversies about diagnosing GH deficiency: a Delphi survey by the GH research society
Pituitary·2025· 5 cited
Outcomes of recombinant growth hormone therapy in the traumatic brain injury population: A scoping review
Best Practice & Research Clinical Endocrinology & Metabolism·2025· 1 cited
page 1 of 12Next →

Frequent Co-authors

Beverly M. K. Biller(16), David M. Cook(9), Andrew R. Hoffman(7), Gudmundur Johannsson(7), David B. Dunger(7), Шломо Мелмед(6), Bradley S. Miller(6), Garni Barkhoudarian(5), César Luiz Boguszewski(5), Ken K. Y. Ho(5), Margaret Cristina da Silva Boguszewski(5), Vera Popović(5), Daniel F. Kelly(5), Vivien Bonert(4), Philippe Chanson(4), Christian J. Strasburger(4), Mary Lee Vance(4), Sally Radovick(4), Martin Bidlingmaier(4), Laurie E. Cohen(4)